A strategy to make constitutively active MAP kinase by fusing with constitutively active MAP kinase kinase

Area of Science:

• Molecular Biology
• Cellular Signaling
• Biochemistry

Background:

• Mitogen-activated protein kinases (MAPKs) are crucial regulators of cellular signal transduction pathways.
• Conventional activation of MAPKs involves phosphorylation by upstream MAPK kinases (MAPKKs) at specific residues.
• Direct mutation of MAPK phosphorylation sites does not yield constitutively active forms.

Purpose of the Study:

• To engineer a novel molecular approach for generating constitutively active mitogen-activated protein kinases (MAPKs).
• To validate the functionality of the engineered constitutively active MAPK in both prokaryotic and eukaryotic systems.
• To explore the potential application of this strategy for other members of the MAPK family.

Main Methods:

• Construction of a fusion protein by linking a nuclear export signal-disrupted, constitutively active MAPKK to wild-type MAPK.
• Expression of the fusion protein in Escherichia coli to assess MAPK phosphorylation and activity.
• Expression of the fusion protein in mammalian cultured cells (NIH-3T3) to evaluate MAPK activation and cellular effects.

Main Results:

• The fusion protein exhibited constitutive MAPK activity upon expression in Escherichia coli, with the MAPK moiety becoming phosphorylated.
• Expression in mammalian cells also resulted in constitutive MAPK activation.
• The activated fusion protein induced significant morphological changes in NIH-3T3 cells.

Conclusions:

• The developed fusion protein functions as a constitutively active MAPK.
• This novel approach offers a viable method for creating constitutively active forms of MAPKs.
• The strategy holds promise for broader application across the MAPK family for research and therapeutic development.